Forecast for Wed 16 Aug 2023 price 0.52
Metacrine, Inc stock price forecast for further price development down to 0.00% (time horizon: 1 day) and price target of 0.00 USD. Short-term (time horizon: 2 weeks) Metacrine, Inc share price prediction for 2023-08-16 with daily closed price projections
Forecast price change %
Relative Strength Index (RSI)
Revenue 0.0
Earnings per share 2.90
On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.
NASH is expected to become the leading cause for liver transplants in the United States. MET642 was generally well-tolerated, with no serious adverse events reported. We believe our product candidates may be used as therapies to treat diseases beyond NASH. We are aware of both private and public companies with development programs in NASH. A single Phase 3 trial may be sufficient in certain circumstances. The cost of preparing and submitting an NDA is substantial. The FDA does not regulate the behavior of physicians in their choice of treatments. The term remuneration has been interpreted broadly to include anything of value. Coverage policies and third-party reimbursement rates may change at any time. The requirements may differ across the EU Member States. Investing in our common stock is speculative and involves a high degree of risk. We were incorporated in 2014 and commenced operations in 2015. As of December 31, 2020, we had an accumulated deficit of $120.7 million. Adequate additional financing may not be available to us on acceptable terms, or at all. In addition, our clinical trials may be affected by the COVID-19 pandemic. We will face significant competition in seeking appropriate collaborators. Collaborations are complex and time consuming to negotiate and document. The degree of future protection for our proprietary rights is uncertain. In this case, we could ultimately be forced to cease use of such trademarks. We may not be able to protect our intellectual property rights throughout the world. Similar requirements exist in Europe. Insurance coverage is increasingly expensive. 62 & We may also be subject to more stringent state law requirements. These shares will become available to be sold on March 16, 2021. Therefore, these provisions could adversely affect the price of our common stock. However, we have not opted out of this provision.
Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.
Institutional ownership list is based on filling form information
| Holding name | Date | Amount |
|---|---|---|
| Allworth Financial LP | 2022-12-31 | 500 |
| Trifecta Capital Advisors, LLC | 2022-12-31 | 4000 |
| BML Capital Management, LLC | 2023-03-31 | 6167458 |
| WEDBUSH SECURITIES INC | 2023-03-31 | 12700 |
| STATE STREET CORP | 2022-12-31 | 72186 |
Fund ownership list is based on filling form information
| Fund name | Date | Amount | Profile |
|---|---|---|---|
| BlackRock Advantage SMID Cap Fund, Inc. | 2022-12-30 | 10531 | Long |
| BlackRock Variable Series Funds, Inc. | 2022-12-31 | 4751 | Long |
| Blackstone Alternative Investment Funds | 2022-12-31 | -6200 | Short |
| BlackRock Advantage SMID Cap Fund, Inc. | 2023-03-31 | 10531 | Long |
| BlackRock Variable Series Funds, Inc. | 2023-03-31 | 4751 | Long |
Bollinger Bollinger Bands for Metacrine, Inc can provide the information where the market is moving based on price information.
Metacrine, Inc Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.
Converting prices to returns Metacrine, Inc.
On-Balance Volume information for Metacrine, Inc. On-Balance Volume information can be an indicator for bullish or bearish outcome.
Accumulation / Distribution (A/D) indicator information for Metacrine, Inc. The indicator identify divergences between price and volume flow.
Aroon Oscillator information for Metacrine, Inc. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.
Average Directional Index (ADX) information for Metacrine, Inc. The index can be used to identify the strengh of a trend.
Moving Average Convergence Divergence (MACD) for Metacrine, Inc. The indicator helps to predict trend direction and the momentum of the trend.
Stochastic Oscillator as momentum indicator for Metacrine, Inc. The indicator is useful for identifying overbought and oversold levels.
Relative Strength Index (RSI) for Metacrine, Inc. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].
Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.
The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.
The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.
Moving Average Crossover
| 52W High | 52W Low | Market Cap |
| Date | Closing price | Prediction was updated |
|---|
The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.
